IBDEI1RB ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,31421,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,31421,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,31422,0)
 ;;=E29.1^^190^1935^49
 ;;^UTILITY(U,$J,358.3,31422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31422,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,31422,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,31422,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,31423,0)
 ;;=E55.9^^190^1935^56
 ;;^UTILITY(U,$J,358.3,31423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31423,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,31423,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,31423,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,31424,0)
 ;;=E66.01^^190^1935^37
 ;;^UTILITY(U,$J,358.3,31424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31424,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,31424,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,31424,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,31425,0)
 ;;=E66.8^^190^1935^41
 ;;^UTILITY(U,$J,358.3,31425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31425,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,31425,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,31425,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,31426,0)
 ;;=E66.9^^190^1935^42
 ;;^UTILITY(U,$J,358.3,31426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31426,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,31426,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,31426,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,31427,0)
 ;;=E74.39^^190^1935^34
 ;;^UTILITY(U,$J,358.3,31427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31427,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,31427,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,31427,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,31428,0)
 ;;=E83.30^^190^1935^44
 ;;^UTILITY(U,$J,358.3,31428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31428,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,31428,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,31428,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,31429,0)
 ;;=E83.51^^190^1935^27
 ;;^UTILITY(U,$J,358.3,31429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31429,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,31429,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,31429,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,31430,0)
 ;;=E83.52^^190^1935^25
 ;;^UTILITY(U,$J,358.3,31430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31430,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,31430,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,31430,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,31431,0)
 ;;=E87.5^^190^1935^26
 ;;^UTILITY(U,$J,358.3,31431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31431,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,31431,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,31431,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,31432,0)
 ;;=E89.2^^190^1935^46
 ;;^UTILITY(U,$J,358.3,31432,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31432,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,31432,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,31432,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,31433,0)
 ;;=E89.6^^190^1935^45
 ;;^UTILITY(U,$J,358.3,31433,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31433,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,31433,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,31433,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,31434,0)
 ;;=L68.0^^190^1935^24
 ;;^UTILITY(U,$J,358.3,31434,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,31434,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,31434,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,31434,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,31435,0)
 ;;=M80.00XA^^190^1935^2
